MedTrace Logo

A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403)

NCT00238875 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 167

Last updated 2016-09-22

No results posted yet for this study

Summary

To evaluate the efficacy and safety of SBRT for T1N0M0 non-small cell lung cancer

Conditions

  • T1N0M0 Non-small Cell Lung Cancer

Interventions

PROCEDURE

stereotactic body radiation therapy

Procedure/Surgery: stereotactic body radiation therapy

Sponsors & Collaborators

  • Ministry of Health, Labour and Welfare, Japan

    collaborator OTHER_GOV

  • Haruhiko Fukuda

    lead OTHER

Principal Investigators

  • Masahiro Hiraoka, MD, PhD · Kyoto Universlty Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2011-11-30
Completion
2011-11-30

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00238875 on ClinicalTrials.gov